drugset / Trial / NCT01967147

Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects

NCT01967147

Completed 279 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to demonstrate the superior efficacy of Systane® Balance over Preservative-Free 0.9% Saline following 35 days of QID (4 times a day) dosing in treating dry eye subjects with lipid deficiency.

Timeline

Start
2014-02
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Propylene Glycol Small molecule 0.6 % Other

Indications